Latest filing published 16 Oct 2026 for MapLight Therapeutics, Inc., €83k. Read the official filing
All filings by James Woodruff Lillie on record concern MapLight Therapeutics, Inc. The record holds 16 filings, for trades running from 27 October 2025 to 15 October 2026.
Sales make up the whole of the open-market record (12 sales, €1.0M). Outside the open market, there are 4 share grants. In 2026 alone, the filings show no purchases and 12 sales.
The latest filing, published on 16 October 2026, reports an open-market sale of €83k in MapLight Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations